Concepedia

Xing Qiu

XQ

Statistics

Publications

11

Citations

472

H-Index

11

Active since

2019

Affiliations

ShanghaiTech University(Current)

Chinese Academy of Sciences

Shanghai Institute of Organic Chemistry

University of North Carolina at Chapel Hill

Icahn School of Medicine at Mount Sinai

Xing Qiu is an author at ShanghaiTech University specializing in medicine, molecular biology, and proteomics.

ORCID

Top concepts

Publications per year

2019–2024

11

Publications

11

Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems

Xiaojuan Qu, Haixia Liu, Xiaoling Song et al. · European Journal of Medicinal Chemistry · 2021 · 102 citations

, , +15

Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance

Ning Sun, Chaowei Ren, Ying Kong et al. · European Journal of Medicinal Chemistry · 2020 · 72 citations · Full text

, , +6

Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction

Xing Qiu, Ning Sun, Ying Kong et al. · Organic Letters · 2019 · 71 citations

, , +11

Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation

Haixia Liu, Xinyu Ding, Linyi Liu et al. · European Journal of Medicinal Chemistry · 2021 · 50 citations

, , +5

Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile

Chaowei Ren, Ning Sun, Haixia Liu et al. · Journal of Medicinal Chemistry · 2021 · 36 citations · Full text

, , +21

1–5 of 11